Veterinary Molecular Diagnostics Market Growth, Trends & Forecast by 2034

Veterinary Molecular Diagnostics Market Size and Forecasts (2021–2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Technology (PCR, Next-Generation Sequencing, Digital PCR, Microarrays); Application (Infectious Diseases, Genetic Testing, Oncology, Toxicology, Blood Typing); Animal Type (Companion Animals, Livestock, Horses, Other Animals); End-User (Veterinary Clinics, Animal Hospitals, Research Institutes, Diagnostic Laboratories); and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00040023
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
Buy Now
Veterinary Molecular Diagnostics Market Growth, Trends & Forecast by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00040023 Email: sales@theinsightpartners.com
Buy Now

2025 Market Size

US$ 1.31 Bn

Base year value

2034 Forecast

US$ 2.61 Bn

Projected by 2034

CAGR 2026-2034

9.00 %

Growth rate

Addressable Market

US$ 18.59 Bn

(2026-2034)

The Veterinary Molecular Diagnostics Market size is expected to reach US$ 2.61 Billion by 2034 from US$ 1.31 Billion in 2025. The market is estimated to record a CAGR of 9.00% from 2026 to 2034.

The report is segmented by Technology (PCR, Next-Generation Sequencing, Digital PCR, Microarrays). The market is further segmented based on by Application (Infectious Diseases, Genetic Testing, Oncology, Toxicology, Blood Typing). The report is segmented based on Animal Type (Companion Animals, Livestock, Horses, Other Animals). The report is segmented based End-User (Veterinary Clinics, Animal Hospitals, Research Institutes, Diagnostic Laboratories). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Veterinary Molecular Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Veterinary Molecular Diagnostics Market Segmentation Technology

  1. PCR
  2. Next-Generation Sequencing
  3. Digital PCR
  4. Microarrays

Application

  1. Infectious Diseases
  2. Genetic Testing
  3. Oncology
  4. Toxicology
  5. Blood Typing

Animal Type

  1. Companion Animals
  2. Livestock
  3. Horses
  4. Other Animals

End-User

  1. Veterinary Clinics
  2. Animal Hospitals
  3. Research Institutes
  4. Diagnostic Laboratories

Market Research Highlights

  • Global market for Veterinary Molecular Diagnostics was valued at US$ 1.31 Billion in 2025
  • Annual market size is expected to reach US$ 2.61 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 18.59 Billion
  • Market is anticipated to register a CAGR of 9% during the forecast period
  • The United States represents a key market, supported by Increasing Pet Ownership, Rising Animal Disease Incidences, Technological Advancements, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expanding Veterinary Services in Emerging Markets, Collaboration with Veterinary Research Institutions, Development of Breed-Specific Diagnostic Kits are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including IDEXX Laboratories, Inc., Zoetis Inc., Thermo Fisher Scientific Inc., Virbac, Qiagen N.V., Biogal Galed Labs, Abaxis Inc. (now part of Zoetis), Randox Laboratories, Neogen Corporation, Randox Laboratories, while analyzing competitive strategies and innovation developments

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Veterinary Molecular Diagnostics Market: Strategic Insights

veterinary-molecular-diagnostics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Veterinary Molecular Diagnostics Market Growth Drivers

  1. Increasing Pet Ownership: The rising trend of pet ownership worldwide, especially in emerging markets, is significantly driving the veterinary molecular diagnostics market. As pet owners become more conscious of their pets' health and seek accurate diagnoses, the demand for advanced molecular diagnostic tools, such as PCR tests, to detect diseases at early stages continues to grow.
  2. Rising Animal Disease Incidences: The growing prevalence of zoonotic diseases and infections in animals is driving demand for molecular diagnostics in veterinary care. Rapid and accurate detection of diseases like Lyme disease, Brucellosis, and FIP (Feline Infectious Peritonitis) is critical to ensure effective treatment and prevent the spread of infections to humans, spurring growth in this market.
  3. Technological Advancements: Continuous innovations in diagnostic technologies, including PCR (Polymerase Chain Reaction), next-generation sequencing (NGS), and digital PCR, are driving the veterinary molecular diagnostics market. These advancements provide more accurate, rapid, and cost-effective diagnostics, improving disease management and treatment for animals and thereby fueling market growth in veterinary healthcare.

Veterinary Molecular Diagnostics Market Future Trends

  1. Point-of-Care Diagnostics: The increasing trend toward point-of-care (POC) diagnostics in veterinary practices is shaping the molecular diagnostics market. These portable and rapid diagnostic tools allow veterinarians to diagnose diseases like viral infections, genetic disorders, and bacterial infections quickly, leading to better treatment decisions and more efficient use of veterinary resources.
  2. Integration with Veterinary Telemedicine: The rise of veterinary telemedicine has accelerated the adoption of molecular diagnostics. Remote consultations, in which diagnostic results are shared and interpreted digitally, have made it easier for veterinary professionals to assess pet health and recommend treatments, driving the market for molecular diagnostic tools that provide accurate and quick results for telemedicine platforms.
  3. Increased Focus on Genetic Testing: With the growing awareness of hereditary diseases in pets, there is a rising demand for genetic testing in veterinary care. Genetic testing helps in early diagnosis, breeding management, and disease prevention, leading to a market trend toward more advanced molecular diagnostic tools focused on pet genetics and inherited conditions.

Veterinary Molecular Diagnostics Market Opportunities

  1. Expanding Veterinary Services in Emerging Markets: The rising disposable income and increasing pet ownership in emerging economies such as Asia-Pacific and Latin America present a significant opportunity for the veterinary molecular diagnostics market. Expanding veterinary healthcare services in these regions will drive the demand for advanced diagnostic solutions and promote market growth.
  2. Collaboration with Veterinary Research Institutions: Collaboration between veterinary diagnostic companies and research institutions offers opportunities to accelerate the development of new diagnostic tests and technologies. These partnerships can lead to the introduction of cutting-edge molecular diagnostic solutions, further driving the veterinary molecular diagnostics market.
  3. Development of Breed-Specific Diagnostic Kits: The growing demand for breed-specific testing for genetic diseases and conditions opens up opportunities for the development of customized diagnostic kits. By focusing on particular breeds and their unique genetic predispositions, companies can create targeted diagnostic solutions, tapping into niche markets and expanding their product offerings

Veterinary Molecular Diagnostics Market Report Scope

Report Attribute Details
Market size in 2025 US$ 1.31 Billion
Market Size by 2034 US$ 2.61 Billion
Global CAGR (2026 - 2034) 9.00%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Technology
  • PCR
  • Next-Generation Sequencing
  • Digital PCR
  • Microarrays
By Application
  • Infectious Diseases
  • Genetic Testing
  • Oncology
  • Toxicology
  • Blood Typing
By Animal Type
  • Companion Animals
  • Livestock
  • Horses
  • Other Animals
By End-User
  • Veterinary Clinics
  • Animal Hospitals
  • Research Institutes
  • Diagnostic Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Virbac
  • Qiagen N.V.
  • Biogal Galed Labs
  • Abaxis Inc. (now part of Zoetis)
  • Randox Laboratories
  • Neogen Corporation
  • Randox Laboratories

Veterinary Molecular Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The Veterinary Molecular Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

veterinary-molecular-diagnostics-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Veterinary Molecular Diagnostics Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Veterinary Molecular Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Key drivers include increasing pet ownership, rising animal disease incidences, and technological advancements in diagnostic tools, particularly PCR and NGS, enabling accurate and rapid disease detection in animals.

The Asia-Pacific region is expected to see the highest growth, driven by rising pet ownership, increasing disposable income, and improving veterinary healthcare infrastructure.

Commonly used technologies include Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), digital PCR, and microarrays, which are used for diagnosing infections, genetic disorders, and cancer in animals.

Opportunities include expanding services in emerging markets, collaborating with research institutions to develop innovative tests, and creating breed-specific diagnostic kits that address the genetic health concerns of particular pet breeds.

Key trends include the shift toward point-of-care diagnostics, integration with veterinary telemedicine, and an increased focus on genetic testing, leading to more personalized and accurate veterinary care.

Approximately 150-200 word file pages is the standard report
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA